JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/07 | 3,240 | 3,240 | 3,160 | 3,200 | -10 | -0.3% | 283,200 |
2021/06/04 | 3,225 | 3,225 | 3,185 | 3,210 | -10 | -0.3% | 207,700 |
2021/06/03 | 3,275 | 3,280 | 3,210 | 3,220 | -20 | -0.6% | 309,100 |
2021/06/02 | 3,265 | 3,270 | 3,205 | 3,240 | -25 | -0.8% | 348,200 |
2021/06/01 | 3,280 | 3,300 | 3,235 | 3,265 | -60 | -1.8% | 369,900 |
2021/05/31 | 3,330 | 3,410 | 3,305 | 3,325 | +30 | +0.9% | 513,900 |
2021/05/28 | 3,230 | 3,300 | 3,230 | 3,295 | +30 | +0.9% | 424,200 |
2021/05/27 | 3,210 | 3,265 | 3,205 | 3,265 | -5 | -0.2% | 476,900 |
2021/05/26 | 3,220 | 3,295 | 3,200 | 3,270 | +35 | +1.1% | 319,500 |
2021/05/25 | 3,260 | 3,290 | 3,210 | 3,235 | -20 | -0.6% | 382,000 |
2021/05/24 | 3,190 | 3,290 | 3,170 | 3,255 | +50 | +1.6% | 696,100 |
2021/05/21 | 3,400 | 3,405 | 3,155 | 3,205 | -170 | -5% | 1,689,800 |
2021/05/20 | 3,390 | 3,450 | 3,345 | 3,375 | +55 | +1.7% | 745,900 |
2021/05/19 | 3,290 | 3,330 | 3,230 | 3,320 | +45 | +1.4% | 521,800 |
2021/05/18 | 3,260 | 3,290 | 3,170 | 3,275 | -45 | -1.4% | 697,500 |
2021/05/17 | 3,275 | 3,385 | 3,230 | 3,320 | -10 | -0.3% | 1,274,000 |
2021/05/14 | 3,310 | 3,330 | 3,150 | 3,330 | +502 | +17.8% | 1,913,300 |
2021/05/13 | 2,862 | 2,871 | 2,778 | 2,828 | -53 | -1.8% | 533,000 |
2021/05/12 | 2,973 | 2,998 | 2,881 | 2,881 | -52 | -1.8% | 616,700 |
2021/05/11 | 3,030 | 3,030 | 2,931 | 2,933 | -127 | -4.2% | 506,500 |
2021/05/10 | 2,990 | 3,060 | 2,970 | 3,060 | +62 | +2.1% | 310,100 |
2021/05/07 | 2,940 | 3,045 | 2,935 | 2,998 | +65 | +2.2% | 394,300 |
2021/05/06 | 2,987 | 2,987 | 2,911 | 2,933 | -42 | -1.4% | 630,000 |
2021/04/30 | 2,969 | 3,025 | 2,940 | 2,975 | +27 | +0.9% | 520,200 |
2021/04/28 | 2,940 | 2,983 | 2,908 | 2,948 | -26 | -0.9% | 548,000 |
2021/04/27 | 2,992 | 3,015 | 2,961 | 2,974 | -26 | -0.9% | 673,500 |
2021/04/26 | 3,075 | 3,075 | 2,989 | 3,000 | -75 | -2.4% | 481,200 |
2021/04/23 | 3,030 | 3,090 | 3,005 | 3,075 | +40 | +1.3% | 410,000 |
2021/04/22 | 3,050 | 3,090 | 3,010 | 3,035 | +15 | +0.5% | 502,000 |
2021/04/21 | 2,963 | 3,080 | 2,963 | 3,020 | +38 | +1.3% | 765,200 |
2021/04/20 | 3,100 | 3,100 | 2,968 | 2,982 | -138 | -4.4% | 904,000 |
2021/04/19 | 3,165 | 3,200 | 3,080 | 3,120 | -105 | -3.3% | 659,100 |
2021/04/16 | 3,285 | 3,290 | 3,200 | 3,225 | -50 | -1.5% | 386,600 |
2021/04/15 | 3,245 | 3,295 | 3,235 | 3,275 | +10 | +0.3% | 274,200 |
2021/04/14 | 3,250 | 3,290 | 3,230 | 3,265 | +45 | +1.4% | 415,500 |
2021/04/13 | 3,240 | 3,240 | 3,195 | 3,220 | ±0 | ±0% | 368,900 |
2021/04/12 | 3,240 | 3,255 | 3,170 | 3,220 | -5 | -0.2% | 499,300 |
2021/04/09 | 3,195 | 3,280 | 3,195 | 3,225 | -5 | -0.2% | 607,700 |
2021/04/08 | 3,270 | 3,275 | 3,185 | 3,230 | -90 | -2.7% | 710,000 |
2021/04/07 | 3,420 | 3,420 | 3,255 | 3,320 | -90 | -2.6% | 1,122,200 |
2021/04/06 | 3,480 | 3,505 | 3,400 | 3,410 | -90 | -2.6% | 604,200 |
2021/04/05 | 3,500 | 3,515 | 3,450 | 3,500 | -50 | -1.4% | 530,700 |
2021/04/02 | 3,605 | 3,645 | 3,540 | 3,550 | -25 | -0.7% | 691,700 |
2021/04/01 | 3,625 | 3,630 | 3,540 | 3,575 | -10 | -0.3% | 605,200 |
2021/03/31 | 3,490 | 3,630 | 3,480 | 3,585 | +90 | +2.6% | 1,001,900 |
2021/03/30 | 3,485 | 3,545 | 3,435 | 3,495 | +10 | +0.3% | 601,800 |
2021/03/29 | 3,520 | 3,565 | 3,460 | 3,485 | -80 | -2.2% | 943,600 |
2021/03/26 | 3,450 | 3,620 | 3,400 | 3,565 | +185 | +5.5% | 2,030,800 |
2021/03/25 | 3,375 | 3,405 | 3,290 | 3,380 | +15 | +0.4% | 618,200 |
2021/03/24 | 3,430 | 3,500 | 3,295 | 3,365 | +5 | +0.1% | 1,087,600 |
851~
900
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム